Can I stop heart meds after cancer therapy?
Part of Cancer, Heart & circulation, Injuries & trauma clinical trials.
This trial tests whether it is safe to stop taking heart failure medications in people who developed heart weakness after cancer treatment but whose heart function has since recovered. It aims to see if stopping these drugs leads to any worsening of heart health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and finished cancer therapy (except some hormone treatments) more than 6 months ago, with no plans for more cancer treatments that could affect your heart.
- You had cancer treatment with anthracyclines and/or HER2-targeted therapy.
- You were diagnosed with moderate to severe heart weakness (asymptomatic) within 1 year after cancer therapy, and your heart function has now recovered to normal (LVEF 50% or higher) on a recent echocardiogram.
- You have been taking at least one heart failure medication for this heart weakness for at least 6 months and currently have no heart failure symptoms.
- Your blood test for NT-proBNP or BNP is within normal limits for your age and sex (doctor will check this).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a personalized, risk-based heart care plan can help prevent heart failure in people who had certain cancer treatments. It focuses on monitoring and guiding treatment, using heart ultrasound results and other health factors.
This trial is testing whether people whose heart failure has improved (with better pumping strength) can safely stop taking some of their heart medications. It is for stable patients who have had significant improvement in their heart function from a low point.
This study tests whether a structured exercise and heart-health rehabilitation program can improve heart function and reduce heart problems in people who have finished cancer treatment or are on stable cancer therapy. If you've had cancer treatment that might affect your heart, this program could help you recover better and live healthier.
This trial tests whether people whose heart function has returned to normal after heart failure can safely stop taking beta-blockers. It aims to see if staying on the medication is still needed or if stopping is just as safe.
This study tests whether patients whose heart failure has improved can safely reduce some of their medications. If your heart function has recovered significantly and stayed stable, this trial explores whether you can gradually lower doses of heart failure drugs while staying healthy.
This study tests a heart medication (sacubitril/valsartan) in young cancer survivors whose hearts were weakened by anthracycline chemotherapy but are not yet having heart failure symptoms. It aims to see if the drug can improve heart function and prevent future problems.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.